시장보고서
상품코드
1090242

세계의 디지털 약국 시장 예측(-2027년) : 의약품별, 제품별, 플랫폼별, 비즈니스 모델별, 출점 지역별

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model(Captive, Franchise, Aggregator), Geographic(Urban, Rural) - Global Forecasts -2027

발행일: | 리서치사: MarketsandMarkets | 페이지 정보: 영문 218 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 디지털 약국 시장 규모는 2022년 965억 달러에서 2027년까지 2,119억 달러에 달할 것으로 예측됩니다.

또한 예측 기간에 연평균 복합 성장률(CAGR)은 17.0%를 나타낼 전망입니다. 시장 성장 주요인으로서 COVID-19 팬데믹 기간과 그 후에 온라인 의약품 구입에 대한 소비자의 선호가 높아진 것, 시장 통합과 파트너십, 고령자 인구 증가 등을 들 수 있습니다. 한편, 임상 지원을 약제사에게 의지하는 환자의 존재, 불법 약국 증가 등이 시장 성장에 방해가 될 가능성도 있습니다.

의약품 유형별로는 시판약이 가장 높은 연평균 복합 성장률(CAGR)로 성장할 전망입니다. 플랫폼별로는 앱 부문이 가장 높은 점유율을 차지하고 있습니다. 출점 지역별로는 도시의 점유율이 높아지고 있습니다. 지역별로는 북미가 최대 시장입니다.

세계의 디지털 약국(Digital Pharmacy) 시장을 분석했으며, 시장의 기본 구조와 최신 상황, 주요 시장 성장 촉진요인 및 억제요인, 시장 동향 전망, 의약품 유형별·제품별·플랫폼별·비즈니스 모델별·출점 지역별·지역별 상세 동향, 시장 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 분석 방법

제3장 개요

제4장 프리미엄 인사이트

  • 디지털 약국 시장 : 개요
  • 디지털 약국 시장 : 제품별
  • 북미의 디지털 약국 시장 : 의약품별/국가별(2021년)
  • 디지털 약국 시장 : 지역별 상황 개요
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • 밸류체인 분석
  • 에코시스템 분석
  • Porter의 산업 분석
  • 가격 결정과 의료비 상환 분석
  • 기술 분석
    • 머신러닝
    • 사물인터넷(IoT)
    • 블록체인
    • 클라우드 컴퓨팅
  • 산업 동향
    • 온라인 처방전의 보충
    • 가상 의료 서비스
    • 디지털 건강진단 툴
  • 주요 컨퍼런스 및 이벤트(2021-2022년)
  • 규제 분석
  • 사례 연구
  • 코로나19(COVID-19) : 디지털 약국 시장에 미치는 영향

제5장 디지털 약국 시장 : 의약품 유형별

  • 서론
  • 처방약(Rx)
  • 시판약(OTC)

제6장 디지털 약국 시장 : 제품별

  • 서론
  • 약물 요법 및 치료
    • 당뇨병 케어
    • 심장질환 케어
    • 종양
  • 퍼스널케어 용품
  • 비타민 및 보충제
  • 기타 제품

제7장 디지털 약국 시장 : 플랫폼별

  • 서론
  • 웹사이트

제8장 디지털 약국 시장 : 비즈니스 모델별

  • 서론
  • 캡티브
  • 프랜차이즈
  • 애그리게이터

제9장 디지털 약국 시장 : 출점 지역별

  • 서론
  • 도시
  • 지방

제10장 디지털 약국 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽 국가
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 기타 아시아태평양 국가
  • 라틴아메리카
  • 중동 및 아프리카

제11장 경쟁 구도

  • 개요
  • 주요 기업의 전략/유력 기업
    • 디지털 약국 시장의 주요 기업이 채용한 전략 : 개요
  • 주요 기업의 매출 점유율 분석
  • 시장 순위
  • 경쟁 벤치마킹
  • 경쟁 리더십 매핑
  • 경쟁 리더십 매핑 : 스타트업/중소기업
  • 경쟁 구도와 동향
    • 제품/서비스 업데이트
    • 자본거래
    • 기타 개발

제12장 기업 개요

  • 주요 기업
    • CVS HEALTH
    • CIGNA
    • OPTUM, INC. (PART OF THE UNITEDHEALTH GROUP)
    • WALGREEN CO.
    • WALMART INC.
    • THE KROGER CO.
    • GIANT EAGLE, INC.
    • AMAZON.COM, INC.
    • PHARMEASY
    • APEX PHARMACY
    • APOLLO PHARMACY
    • RITE AID CORP
    • COSTCO WHOLESALE CORPORATION
  • 기타 기업
    • SHOP-APOTHEKE.COM
    • NETMEDS.COM
    • DOCMORRIS
    • TATA 1MG
    • LLOYDSPHARMACY
    • GOODRX, INC.
    • HEALTHWAREHOUSE.COM
    • TELUS HEALTH
    • PHARMEX DIRECT INC.
    • HIMS & HERS HEALTH, INC.
    • RO PHARMACY
    • RX OUTREACH
    • THE INDEPENDENT PHARMACY
    • REXALL PHARMACY GROUP ULC
    • NORTHWESTPHARMACY.COM

제13장 부록

LSH 22.06.24

The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population.

However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period.

"Over-the-counter (OTC) productssegment isestimated to grow at the highest rate during the forecast period"

On the basis ofdrug type, the digital pharmacy market is segmented into prescription medicines and over-the-counter products. Prescription medicines accounted for the largest share of the global digital pharmacy market in 2021. The large share of this market segment can be attributed to factors such as growing prevalence of several chronic disorders and the subsequent growing demand for medications.

On the other hand, the over-the-counter (OTC) products segment isexpected to grow at the highest CAGR during the forecast period. Growth in this market segment is largely driven by the widespread availability and cost-effectiveness of over-the-counter products and the growing trend of self-medication.

"The Medicines & Treatmentssegment is expected to account for the largest share of theDigital Pharmacymarket in 2021"

On the basis ofproducts, the digital pharmacy market is segmented into medicines & treatments, personal care products, vitamins & supplements, and other products. The medicines & treatments segment accounted for the largest share of the global digital pharmacy market in 2021.

However, the vitamins & supplements segment is expected to register the highest CAGR during the forecast period due to increase prevalence of chronic diseases and the availability of multiple product options.

"Appssegment in the platformis expected to account for the largest share of the global digital pharmacy market"

On the basis ofplatforms, the digital pharmacy market is segmented into apps and websites. In 2021, apps is expected to hold the largest share of the global digital pharmacy market, growth in this segment is attributed to factors as the appsoffer lucrative promos or discounts to attract customers.The websitesplatform is estimated to grow at the second-highest CAGR during the forecast period due to convenience, privacy, and safety offered by websites are key factors driving the market growth.

"Captive segmentamong the business model accounted for the largest share of the global digital pharmacy market in 2021"

On the basis ofbusiness models, the digital pharmacy market is segmented into captive, franchise, and aggregator business models. The captive business model accounted for the largest share of the global digital pharmacy market in 2021 The captive business model is also estimated to register the highest CAGR during the forecast period. The flexibility, accessibility, and affordability of captive business models are key factors to segmental growth in the digital pharmacy market. The aggregator business model is estimated to grow at the second-highest CAGR during the forecast period.

"The Urbanareasaccounted for the largest share of the global digital pharmacy market in 2021"

On the basis ofgeographic coverage, the digital pharmacy market is segmented into urban and rural areas. Urban areas accounted for the largest share of the global digital pharmacy market in 2021 due to the growing penetration of the internet in urban areas.

"North America todominate the digital pharmacy market during forecast period"

North America accounted for the largest share of the digital pharmacy market in 2022. The growing prevalence of chronic conditions, the rising number of drug prescriptions resulting from the rapidly growing aging population, and the presence of key market players in the region are the key factors driving the growth of the digital pharmacy market in North America.

The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the growing disease burden, growing patient population, and the rapidly growing pharmaceutical market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (41%), Tier 2(31%), and Tier 3 (28%)
  • By Designation: C-level (44%), Director-level (35%), and Others (21%)
  • By Region: North America (46%), Europe (26%), Asia Pacific(18%),Latin America (7%) and Middle East & Africa (3%)

Prominent players in this market are CVS Health (US), Cigna (US), Optum, Inc. (Part of the UnitedHealth Group) (US), Walgreens Co. (US), Walmart Inc. (US), The Kroger Co. (US), Amazon.com, Inc. (US), GoodRx (US), Costco Wholesale Corporation (US), Rite Aid Corp. (US), Hims& Hers Health, Inc. (US), PharmEasy (India), Apollo Pharmacy (India), DocMorris (Netherlands), Giant Eagle Inc. (US), LloydsPharmacy (UK), Shop-apotheke.com (Netherlands), Tata 1mg (India), Netmeds.com (India), HealthWarehouse, Inc. (US), Pharmex Direct Inc. (Canada), Apex Pharmacy (UK), TELUS (Canada), RO Pharmacy (US), Rx Outreach (US), The Independent Pharmacy (UK), Rexall Pharmacy Group ULC (Canada), and NorthWestPharmacy.com (Canada).These players are increasingly focusing on product/service upgrades, acquisitions, partnerships, agreements, expansions, and collaborations to expand their product offerings in the digital pharmacy market.

Research Coverage

  • The report studies theDigital Pharmacymarket based on drug type, products,platform,business model,geographic coverage, and region
  • The report analyzes factors (such as drivers, restraints, opportunities, andchallenges) affecting the market growth
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
  • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total digital pharmacy market
  • The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Digital Pharmacy market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 DIGITAL PHARMACY MARKET: INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 DIGITAL PHARMACY MARKET
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
    • 1.5.1 SCOPE-RELATED LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET ESTIMATION
    • 2.2.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 2.2.2 APPROACH: REVENUE MAPPING-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
    • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION FOR CVS HEALTH
    • 2.2.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
    • FIGURE 7 DIGITAL PHARMACY MARKET: TOP-DOWN APPROACH
    • 2.2.4 GROWTH FORECAST
    • FIGURE 8 IMPACT OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ON MARKET GROWTH & CAGR
    • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 ASSUMPTIONS FOR THE STUDY
  • 2.5 LIMITATIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: DIGITAL PHARMACY MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 DIGITAL PHARMACY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 DIGITAL PHARMACY MARKET, BY PLATFORM, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET

4 PREMIUM INSIGHTS

  • 4.1 DIGITAL PHARMACY MARKET OVERVIEW
    • FIGURE 17 GROWING GERIATRIC POPULATION TO DRIVE THE MARKET GROWTH
  • 4.2 DIGITAL PHARMACY MARKET, BY PRODUCT
    • FIGURE 18 MEDICINES & TREATMENTS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PHARMACY MARKET IN 2021
  • 4.3 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG & COUNTRY (2021)
    • FIGURE 19 PRESCRIPTION MEDICINES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
  • 4.4 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET
    • FIGURE 20 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • 4.5 MARKET DYNAMICS
    • FIGURE 21 DIGITAL PHARMACY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 4.5.1 DRIVERS
      • 4.5.1.1 Increasing consumer preference toward buying online medicines during and post the COVID-19 pandemic
    • TABLE 2 TOTAL NUMBER OF CONFIRMED CORONAVIRUS CASES, BY REGION (AS OF JANUARY 7, 2022)
      • 4.5.1.2 Consolidation in the market and partnerships
      • 4.5.1.3 Growing geriatric population
    • TABLE 3 GLOBAL OVERVIEW OF THE RISE IN THE AGING POPULATION (MILLION)
    • 4.5.2 RESTRAINTS
      • 4.5.2.1 Growing number of illegal pharmacies
      • 4.5.2.2 Risk of counterfeit drugs
      • 4.5.2.3 Increased risk of drug abuse
    • 4.5.3 OPPORTUNITIES
      • 4.5.3.1 Emerging markets
      • 4.5.3.2 Benefits of E-commerce
    • 4.5.4 CHALLENGES
      • 4.5.4.1 Challenges for patients relying on pharmacists for clinical support
      • 4.5.4.2 Lack of strong national laws worldwide
      • 4.5.4.3 Security and privacy concerns
  • 4.6 VALUE CHAIN ANALYSIS
  • 4.7 ECOSYSTEM ANALYSIS
  • 4.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 DIGITAL PHARMACY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 4.8.1 INTENSITY OF COMPETITIVE RIVALRY
    • 4.8.2 BARGAINING POWER OF SUPPLIERS
    • 4.8.3 BARGAINING POWER OF BUYERS
    • 4.8.4 THREAT FROM SUBSTITUTES
    • 4.8.5 THREAT FROM NEW ENTRANTS
  • 4.9 PRICING & REIMBURSEMENT ANALYSIS
    • TABLE 5 COMPARISON OF AVERAGE DISCOUNTED PRICES FOR A ONE-MONTH SUPPLY OF DRUGS
  • 4.10 TECHNOLOGY ANALYSIS
    • 4.10.1 MACHINE LEARNING
    • 4.10.2 INTERNET OF THINGS
    • 4.10.3 BLOCKCHAIN
    • 4.10.4 CLOUD COMPUTING
  • 4.11 INDUSTRY TRENDS
    • 4.11.1 ONLINE PRESCRIPTION REFILL
    • 4.11.2 VIRTUAL HEALTHCARE SERVICES
    • 4.11.3 DIGITAL HEALTH DIAGNOSTIC TOOLS
  • 4.12 KEY CONFERENCES & EVENTS IN 2021-2022
  • 4.13 REGULATORY ANALYSIS
    • 4.13.1 NORTH AMERICA
      • 4.13.1.1 US
      • 4.13.1.2 Canada
    • 4.13.2 EUROPE
    • 4.13.3 ASIA PACIFIC
    • 4.13.4 REST OF THE WORLD
    • TABLE 6 APPROACHES OF REGULATORY AUTHORITIES (RA) WORLDWIDE TO CONTROL MEDICINAL PRODUCT ONLINE SALES
  • 4.14 CASE STUDIES
    • 4.14.1 MAGENTO 2 WEB APP MODERNIZATION
      • 4.14.1.1 Use Case 1: Need to Revamp Online Store
    • 4.14.2 WALMART REACT NATIVE PHARMACY
      • 4.14.2.1 Use Case 2: Need to Rebuild Pharmacy App
  • 4.15 IMPACT OF COVID-19 ON THE DIGITAL PHARMACY MARKET

5 DIGITAL PHARMACY MARKET, BY DRUG TYPE

  • 5.1 INTRODUCTION
    • TABLE 7 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
  • 5.2 PRESCRIPTION MEDICINES
    • 5.2.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN CHRONIC DISEASES TO DRIVE THE DEMAND FOR PRESCRIPTION MEDICATION
    • TABLE 8 DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 9 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 10 EUROPE: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 5.3 OVER-THE-COUNTER PRODUCTS
    • 5.3.1 EASE OF USE AND CONVENIENCE ASSOCIATED WITH OVER-THE-COUNTER PRODUCTS TO DRIVE MARKET GROWTH
    • TABLE 11 DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 12 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 13 EUROPE: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)

6 DIGITAL PHARMACY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 14 DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 6.2 MEDICINES & TREATMENTS
    • TABLE 15 DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 16 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 17 EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 18 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 19 DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • 6.2.1 DIABETES CARE
      • 6.2.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments
    • TABLE 20 DIGITAL PHARMACY MARKET FOR DIABETES CARE MEDICINES & TREATMENTS, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.2 HEART CARE
      • 6.2.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments
    • TABLE 21 DIGITAL PHARMACY MARKET FOR HEART CARE MEDICINES & TREATMENTS, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.3 ONCOLOGY
      • 6.2.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment
    • TABLE 22 DIGITAL PHARMACY MARKET FOR ONCOLOGY MEDICINES & TREATMENTS, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.3.2 Other medicines & treatments
    • TABLE 23 DIGITAL PHARMACY MARKET FOR OTHER MEDICINES & TREATMENTS, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 PERSONAL CARE PRODUCTS
    • 6.3.1 GROWING FOCUS ON PERSONAL HEALTH & HYGIENE TO DRIVE MARKET GROWTH
    • TABLE 24 DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 25 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 26 EUROPE: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 27 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.4 VITAMINS & SUPPLEMENTS
    • 6.4.1 GROWING DEMAND FOR IMMUNITY-ASSOCIATED SUPPLEMENTS IN THE WAKE OF THE COVID-19 PANDEMIC TO DRIVE MARKET GROWTH
    • TABLE 28 DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 29 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 30 EUROPE: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.5 OTHER PRODUCTS
    • TABLE 32 DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 33 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 34 EUROPE: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)

7 DIGITAL PHARMACY MARKET, BY PLATFORM

  • 7.1 INTRODUCTION
    • TABLE 36 DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
  • 7.2 APPS
    • 7.2.1 ADVANTAGES SUCH AS CONTACTLESS DELIVERY WILL DRIVE THE DEMAND FOR APPS
    • TABLE 37 DIGITAL PHARMACY APPS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 38 NORTH AMERICA: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 39 EUROPE: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 40 ASIA PACIFIC: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 WEBSITES
    • 7.3.1 PROMOTIONS, DISCOUNTS, AND OFFERS PROVIDED BY WEBSITES TO DRIVE MARKET GROWTH
    • TABLE 41 DIGITAL PHARMACY WEBSITES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 42 NORTH AMERICA: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 43 EUROPE: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 44 ASIA PACIFIC: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL

  • 8.1 INTRODUCTION
    • TABLE 45 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
  • 8.2 CAPTIVE
    • 8.2.1 FLEXIBILITY, ACCESSIBILITY, AND AFFORDABILITY OF CAPTIVE MODELS- KEY FACTORS DRIVING MARKET GROWTH
    • TABLE 46 DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 47 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 48 EUROPE: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 FRANCHISE
    • 8.3.1 GROWING NUMBER OF PHARMACY FRANCHISES TO DRIVE MARKET GROWTH
    • TABLE 50 DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 51 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 52 EUROPE: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 53 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 AGGREGATOR
    • 8.4.1 QUALITY SERVICES ASSOCIATED WITH AGGREGATOR MODELS TO DRIVE MARKET GROWTH
    • TABLE 54 DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 55 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 56 EUROPE: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020-2027 (USD MILLION)

9 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE

  • 9.1 INTRODUCTION
    • TABLE 58 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020-2027 (USD MILLION)
  • 9.2 URBAN AREAS
    • 9.2.1 RAPID INTERNET PENETRATION IN URBAN AREAS TO DRIVE MARKET GROWTH IN THIS SEGMENT
    • TABLE 59 DIGITAL PHARMACY MARKET IN URBAN AREAS, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 RURAL AREAS
    • 9.3.1 GOVERNMENT INITIATIVES TO FUEL THE DEMAND FOR DIGITAL PHARMACIES IN RURAL AREAS
    • TABLE 60 DIGITAL PHARMACY MARKET IN RURAL AREAS, BY REGION, 2020-2027 (USD MILLION)

10 DIGITAL PHARMACY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 61 DIGITAL PHARMACY MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • 10.2.1 IMPACT OF COVID-19 ON THE NORTH AMERICAN DIGITAL PHARMACY MARKET
    • FIGURE 22 NORTH AMERICA: DIGITAL PHARMACY MARKET SNAPSHOT
    • TABLE 62 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 63 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 64 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 65 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 66 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 67 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • TABLE 68 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020-2027 (USD MILLION)
    • 10.2.2 US
      • 10.2.2.1 The US is the largest regional market for digital pharmacy, mainly due to the rising prevalence of chronic conditions and the growing number of prescriptions
    • TABLE 69 US: KEY MACROINDICATORS
    • TABLE 70 US: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 US: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 72 US: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 73 US: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 74 US: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • TABLE 75 US: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020-2027 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Rising drug expenditures to propel market growth in Canada
    • TABLE 76 CANADA: KEY MACROINDICATORS
    • TABLE 77 CANADA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 78 CANADA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 79 CANADA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 80 CANADA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 81 CANADA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • TABLE 82 CANADA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • 10.3.1 IMPACT OF COVID-19 ON THE EUROPEAN DIGITAL PHARMACY MARKET
    • TABLE 83 EUROPE: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 84 EUROPE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 85 EUROPE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 86 EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 EUROPE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 88 EUROPE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Germany is the fastest-growing market for digital pharmacies in Europe
    • TABLE 89 GERMANY: KEY MACROINDICATORS
    • TABLE 90 GERMANY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 91 GERMANY: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 92 GERMANY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 GERMANY: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 94 GERMANY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Rising initiatives to improve the safety of digital pharmacies to boost the market growth
    • TABLE 95 UK: KEY MACROINDICATORS
    • TABLE 96 UK: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 UK: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 98 UK: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 UK: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 100 UK: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 Rising geriatric population in the country to support market growth
    • TABLE 101 FRANCE: KEY MACROINDICATORS
    • TABLE 102 FRANCE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 FRANCE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 104 FRANCE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 FRANCE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 106 FRANCE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Growing burden of chronic diseases is driving the market growth in Italy
    • TABLE 107 ITALY: KEY MACROINDICATORS
    • TABLE 108 ITALY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 ITALY: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 110 ITALY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 ITALY: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 112 ITALY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Increasing focus on improving the healthcare infrastructure in the country to support market growth
    • TABLE 113 SPAIN: KEY MACROINDICATORS
    • TABLE 114 SPAIN: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 115 SPAIN: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 116 SPAIN: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 117 SPAIN: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 118 SPAIN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.3.7 ROE
    • TABLE 119 ROE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 ROE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 121 ROE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 122 ROE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 123 ROE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 IMPACT OF COVID-19 ON THE ASIA PACIFIC DIGITAL PHARMACY MARKET
    • FIGURE 23 ASIA PACIFIC: DIGITAL PHARMACY MARKET SNAPSHOT
    • TABLE 124 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 126 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing consumer demand for OTC products to drive the market for digital pharmacy in China
    • TABLE 128 CHINA: KEY MACROINDICATORS
    • TABLE 129 CHINA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 130 CHINA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 131 CHINA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Rising healthcare expenditures and the growing burden of non-communicable diseases (NCDs) to drive market growth in Japan
    • TABLE 132 JAPAN: KEY MACROINDICATORS
    • TABLE 133 JAPAN: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 134 JAPAN: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 135 JAPAN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Favorable government initiatives and high density of rural population to support market growth in India
    • TABLE 136 INDIA: KEY MACROINDICATORS
    • TABLE 137 INDIA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 138 INDIA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 139 INDIA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 INDIA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 141 INDIA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 142 ROAPAC: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 ROAPAC: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 144 ROAPAC: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 145 ROAPAC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 GROWING INTERNET USERS WILL FAVOR MARKET GROWTH IN LATAM
      • 10.5.1.1 Impact of COVID-19 on the Latin American digital pharmacy market
    • TABLE 146 LATIN AMERICA: KEY MACROINDICATORS
    • TABLE 147 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 148 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 149 LATIN AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 151 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 INCREASING DEMAND FOR ONLINE PHARMACEUTICAL PRODUCTS WILL DRIVE THE MARKET IN THE MEA
      • 10.6.1.1 Impact of COVID-19 on the Middle East & Africa digital pharmacy market
    • TABLE 152 MEA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 MEA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 154 MEA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 155 MEA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020-2027 (USD MILLION)
    • TABLE 156 MEA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE DIGITAL PHARMACY MARKET
  • 11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
  • 11.4 MARKET RANKING
    • FIGURE 24 US DIGITAL PHARMACY MARKET RANKING, BY KEY PLAYER, 2021
  • 11.5 COMPETITIVE BENCHMARKING
    • 11.5.1 OVERALL COMPANY FOOTPRINT
    • TABLE 157 OVERALL COMPANY FOOTPRINT
    • 11.5.2 COMPANY DRUG TYPE FOOTPRINT
    • TABLE 158 COMPANY DRUG TYPE FOOTPRINT
    • 11.5.3 COMPANY PRODUCT FOOTPRINT
    • TABLE 159 COMPANY PRODUCT FOOTPRINT
    • 11.5.4 COMPANY PLATFORM FOOTPRINT
    • TABLE 160 COMPANY PLATFORM FOOTPRINT
    • 11.5.5 COMPANY REGIONAL FOOTPRINT
    • TABLE 161 COMPANY REGIONAL FOOTPRINT
    • TABLE 162 DIGITAL PHARMACY MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 11.6 COMPETITIVE LEADERSHIP MAPPING
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • FIGURE 25 DIGITAL PHARMACY MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
  • 11.7 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 STARTING BLOCKS
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 DYNAMIC COMPANIES
    • FIGURE 26 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME MATRIX MARKET
  • 11.8 COMPETITIVE SITUATIONS AND TRENDS
    • 11.8.1 PRODUCT/SERVICE UPGRADES
    • 11.8.2 DEALS
    • 11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 CVS HEALTH
    • TABLE 163 CVS HEALTH: BUSINESS OVERVIEW
    • FIGURE 27 CVS HEALTH: COMPANY SNAPSHOT (2021)
    • 12.1.2 CIGNA
    • TABLE 164 CIGNA: BUSINESS OVERVIEW
    • FIGURE 28 CIGNA: COMPANY SNAPSHOT (2021)
    • 12.1.3 OPTUM, INC. (PART OF THE UNITEDHEALTH GROUP)
    • TABLE 165 OPTUM, INC.: BUSINESS OVERVIEW
    • FIGURE 29 OPTUM, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.4 WALGREEN CO.
    • TABLE 166 WALGREEN CO.: BUSINESS OVERVIEW
    • FIGURE 30 WALGREEN CO.: COMPANY SNAPSHOT (2021)
    • 12.1.5 WALMART INC.
    • TABLE 167 WALMART INC.: BUSINESS OVERVIEW
    • FIGURE 31 WALMART INC.: COMPANY SNAPSHOT (2021)
    • 12.1.6 THE KROGER CO.
    • TABLE 168 THE KROGER CO.: BUSINESS OVERVIEW
    • FIGURE 32 THE KROGER CO.: COMPANY SNAPSHOT (2020)
    • 12.1.7 GIANT EAGLE, INC.
    • TABLE 169 GIANT EAGLE, INC.: BUSINESS OVERVIEW
    • 12.1.8 AMAZON.COM, INC.
    • TABLE 170 AMAZON.COM, INC.: BUSINESS OVERVIEW
    • FIGURE 33 AMAZON.COM, INC.: COMPANY SNAPSHOT (2020)
    • 12.1.9 PHARMEASY
    • TABLE 171 PHARMEASY: BUSINESS OVERVIEW
    • 12.1.10 APEX PHARMACY
    • TABLE 172 APEX PHARMACY: BUSINESS OVERVIEW
    • 12.1.11 APOLLO PHARMACY
    • TABLE 173 APOLLO PHARMACY: BUSINESS OVERVIEW
    • FIGURE 34 APOLLO HOSPITAL: COMPANY SNAPSHOT (2021)
    • 12.1.12 RITE AID CORP
    • TABLE 174 RITE AID CORP.: BUSINESS OVERVIEW
    • FIGURE 35 RITE AID CORP.: COMPANY SNAPSHOT (2021)
    • 12.1.13 COSTCO WHOLESALE CORPORATION
    • TABLE 175 COSTCO WHOLESALE CORPORATION: BUSINESS OVERVIEW
    • FIGURE 36 COSTCO WHOLESALE CORPORATION: COMPANY SNAPSHOT (2021)
  • 12.2 OTHER KEY PLAYERS
    • 12.2.1 SHOP-APOTHEKE.COM
    • 12.2.2 NETMEDS.COM
    • 12.2.3 DOCMORRIS
    • 12.2.4 TATA 1MG
    • 12.2.5 LLOYDSPHARMACY
    • 12.2.6 GOODRX, INC.
    • 12.2.7 HEALTHWAREHOUSE.COM
    • 12.2.8 TELUS HEALTH
    • 12.2.9 PHARMEX DIRECT INC.
    • 12.2.10 HIMS & HERS HEALTH, INC.
    • 12.2.11 RO PHARMACY
    • 12.2.12 RX OUTREACH
    • 12.2.13 THE INDEPENDENT PHARMACY
    • 12.2.14 REXALL PHARMACY GROUP ULC
    • 12.2.15 NORTHWESTPHARMACY.COM
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제